Galectin Therapeutics Inc.

Norcross, Georgia, United States galectintherapeutics.com

Overview

Galectin Therapeutics Inc. is a biotechnology company focused on developing therapies based on galectin proteins to treat fibrotic disease, liver disease, cancer, and other diseases. The company is pioneering the development of new therapies for advanced fibrosis in non-alcoholic steatohepatitis (NASH) and cancer immunotherapy.

Therapeutic areas

Fibrotic diseaseLiver diseaseCancer

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Galectin Therapeutics Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.

Related companies

Altimmune, Inc.
United States
Cancer Research Institute, Inc.
USA
Cayman Chemical Company
United States
City of Hope National Medical Center
United States
Emory University
United States
Gilead Sciences, Inc.
United States
Lexicon Pharmaceuticals, Inc.
United States
Repertoire Immune Medicines, Inc.
United States

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo